XML 29 R14.htm IDEA: XBRL DOCUMENT
v3.24.1

Note 7 - Accrued Expenses and Other Current Liabilities | 12 Months Ended
--- | ---
Dec. 31, 2023
Notes to Financial Statements |
Accrued Liabilities and Other Current Liabilities Disclosure [Text Block] |
(7) | Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following (in thousands):
|  | December 31, |  |  | December 31, |
|  | 2023 |  |  | 2022 |
Accrued expenses |  | $ | 75 |  |  | $ | 157 |
Accrued salaries and employee benefits |  |  | 661 |  |  |  | 899 |
Accrued clinical trial costs |  |  | 1,017 |  |  |  | 548 |
Grant liability |  |  | 471 |  |  |  | 534 |
Customer deposits |  |  | 90 |  |  |  | 90 |
Payable to related party |  |  | 71 |  |  |  | 18 |
Total |  | $ | 2,385 |  |  | $ | 2,246 |

X
- Definition The entire disclosure for accrued liabilities and other current liabilities at the end of the reporting period. + References No definition available. + Details
Name: | bcda_AccruedLiabilitiesAndOtherCurrentLiabilitiesDisclosureTextBlock
Namespace Prefix: | bcda_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration